Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Nursing Ethics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Press, N.
Right arrow Articles by Koenig, B. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Press, N.
Right arrow Articles by Koenig, B. A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Collective Fear, Individualized Risk: the social and cultural context of genetic testing forbreast cancer

Nancy Press

Stanford University Center of Biomedical Ethics, Palo Alto, CA, USA

Jennifer R Fishman

Stanford University Center of Biomedical Ethics, Palo Alto, CA, USA

Barbara A Koenig

Stanford University Center of Biomedical Ethics, Palo Alto, CA, USA

The purpose of this article is to provide a critical examination of two aspects of culture and biomedicine that have helped to shape the meaning and practice of genetic testing for breast cancer. These are: (1) the cultural construction of fear of breast cancer, which has been fuelled in part by (2) the predominance of a ‘risk’ paradigm in contemporary biomedicine. The increasing elaboration and delineation of risk factors and risk numbers are in part intended to help women to contend with their fear of breast cancer. However, because there is no known cure or foolproof prevention for breast cancer, risk designations bring with them recommendations for vigilant surveillance strategies and screening guidelines. We argue that these in effect exacerbate women’s fears of breast cancer itself. The volatile combination of discourses of fear, risk and surveillance have significant ethical and social consequences for women’s lives and well-being. Genetic testing decisions are made within this context; if nurses understand this context they can play an important role in helping women to cope with the anxiety and fear of breast cancer risk.

Key Words: breast cancer • culture • ethics • genetic testing • risk

Nursing Ethics, Vol. 7, No. 3, 237-249 (2000)
DOI: 10.1177/096973300000700306
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
S. E. Gollust, S. C. Hull, and B. S. Wilfond
Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing
JAMA, October 9, 2002; 288(14): 1762 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 Health (London)Home page
L. F. Hogle
Chemoprevention for Healthy Women: Harbinger of Things to Come?
Health (London) , July 1, 2001; 5(3): 311 - 333.
[Abstract] [PDF]

Home page
 Nurs EthicsHome page
J. Pasacreta, N. Press, J. Fishman, and B. Koenig
Letter to the Editor
Nursing Ethics, March 1, 2001; 8(2): 161 - 163.
[PDF]